Genetic biochemical and pathophysiological characterization of a familial mitochondrial encephalomyopathy (MERRF)
- PMID: 1661776
- DOI: 10.1016/0022-510x(91)90148-z
Genetic biochemical and pathophysiological characterization of a familial mitochondrial encephalomyopathy (MERRF)
Abstract
Myoclonic epilepsy with ragged-red fibers (MERRF) syndrome is a neuromuscular disorder characterized by mitochondrial myopathy and progressive myoclonus epilepsy. A heteroplasmic A to G transition mutation in the mitochondrial encoded tRNA(Lys) gene at nucleotide pair 8344 has been suggested to be linked to the MERRF-syndrome. We have investigated biochemically and histochemically muscle biopsies and studied the mitochondrial genomes of hair, blood and muscle tissue of a family including three cases of MERRF-syndrome as well as unaffected relatives within the maternal lineage. Sequence analysis of the mtDNAs, performed after amplification by the polymerase chain reaction (PCR), confirmed the A to G transition mutation in the tRNA(Lys) gene at position 8344. The additional point mutation at nucleotide pair 750 in the 12 S rRNA gene, which was also found by Shoffner et al. (1990), however, was absent in all investigated tissues. Quantitative analysis of the percentage of mutated mtDNA by mispairing PCR (Seibel et al., 1990) revealed variable contents in different tissues and individuals, including unaffected family members. Mitochondrial protein synthesis in cultured fibroblasts from MERRF patients revealed diminished incorporation of 35S-methionine into lysine-containing peptides.
Similar articles
-
Rapid detection of the A----G(8344) mutation of mtDNA in Italian families with myoclonus epilepsy and ragged-red fibers (MERRF).Am J Hum Genet. 1991 Feb;48(2):203-11. Am J Hum Genet. 1991. PMID: 1899320 Free PMC article.
-
Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation.Cell. 1990 Jun 15;61(6):931-7. doi: 10.1016/0092-8674(90)90059-n. Cell. 1990. PMID: 2112427
-
A tRNA(Lys) mutation in the mtDNA is the causal genetic lesion underlying myoclonic epilepsy and ragged-red fiber (MERRF) syndrome.Am J Hum Genet. 1991 Oct;49(4):715-22. Am J Hum Genet. 1991. PMID: 1910259 Free PMC article.
-
MERRF: a model disease for understanding the principles of mitochondrial genetics.Rev Neurol (Paris). 1991;147(6-7):431-5. Rev Neurol (Paris). 1991. PMID: 1962048 Review.
-
[Molecular genetic analysis for myoclonus epilepsy associated with ragged-red fibers (MERRF)].Nihon Rinsho. 1993 Sep;51(9):2379-85. Nihon Rinsho. 1993. PMID: 8411716 Review. Japanese.
Cited by
-
Mitochondrial cardiomyopathies: navigating through different clinical and management pictures between adult and paediatric forms.Front Cardiovasc Med. 2025 Jul 3;12:1621096. doi: 10.3389/fcvm.2025.1621096. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40678571 Free PMC article. Review.
-
Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF).Am J Hum Genet. 1992 Dec;51(6):1187-200. Am J Hum Genet. 1992. PMID: 1334369 Free PMC article.
-
Immunohistochemical analysis of muscle cytochrome c oxidase deficiency in children.Histochem Cell Biol. 1995 Jan;103(1):59-68. doi: 10.1007/BF01464476. Histochem Cell Biol. 1995. PMID: 7736281 Clinical Trial.
-
Cardiovascular Outcomes in Patients With Mitochondrial Disease in the United States: A Propensity Score Analysis.Tex Heart Inst J. 2021 Jul 1;48(3):e207243. doi: 10.14503/THIJ-20-7243. Tex Heart Inst J. 2021. PMID: 34383956 Free PMC article.
-
Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management.Eur Heart J. 2012 Dec;33(24):3023-33. doi: 10.1093/eurheartj/ehs275. Epub 2012 Aug 30. Eur Heart J. 2012. PMID: 22936362 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources